Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.

12 January 2021 The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV.

12 January 2021 The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV. This document is also available in Arabic and Portuguese

12 January 2021 The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV.

Applying the evidence of what works from HIV-related stigma and discrimination in six settings to the COVID-19 response This brief provide evidence-informed guidance to countries on the intersection of stigma related to HIV and COVID-19 in national responses

COVID-19 является серьезным заболеванием, и все люди, живущие с ВИЧ, должны принять все рекомендуемые профилактические меры, чтобы минимизировать воздействие и предотвратить заражение вирусом, вызывающим COVID-19. Как и в общей популяции, пожилые люди, живущие с ВИЧ, или люди, живущие с ВИЧ с проблемами сердца или легких, могут подвергаться более высокому риску заражения вирусом и иметь более серьезные симптомы. What people living with HIV need to know about HIV and COVID-1

Applying the evidence of what works from HIV-related stigma and discrimination in six settings to the COVID-19 response This brief provide evidence-informed guidance to countries on the intersection of stigma related to HIV and COVID-19 in national responses

how to seize the moment to learn, leverage and build a new way forward for everyone’s health and rights This new report by UNAIDS examines how the experience of tackling HIV can help inform and guide effective, efficient, people-centred and sustainable COVID-19 responses

Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов вРоссии ивлияния эпидемии коронавирусной инфекции COVID-19 на оказание медицинской помощипри ВИЧ-инфекции» This study shows the negative impact that the COVID-19 pandemic is having on access to HIV care in the Russian Federation and shows that people living with HIV in the country are more susceptible to COVID-19 but less likely to seek testing or treatment. More than a third of people living with HIV who were surveyed reported some impact on HIV services, including about 4% who reported that they had missed taking antiretroviral therapy because they could not get the medicine and nearly 9% who reported that they had missed taking medicine for tuberculosis prevention. However, the majority of respondents (about 70% of people living with HIV) did not experience problems obtaining antiretroviral therapy and about 22% reported that antiretroviral medicines were delivered to their home. More than 900 respondents from 68 regions of the Russian Federation, including people living with HIV and those who are not, were reached by the study

COVID-19 является серьезным заболеванием, и все люди, живущие с ВИЧ, должны принять все рекомендуемые профилактические меры, чтобы минимизировать воздействие и предотвратить заражение вирусом, вызывающим COVID-19